Profil
Tobias Larsson Agervald is Chief Executive Officer at Guard Therapeutics International AB since 2019 and Director at TE Medical Consulting AB since 2018.
Former roles include Senior Medical Director at Astellas Pharma Global Development, Inc. and Associate Professor at Karolinska Institutet.
Education includes doctorates from the University of Uppsala and Harvard Medical School.
Aktiva positioner av Tobias Larsson Agervald
| Företag | Position | Start |
|---|---|---|
| DISRUPTIVE PHARMA AB | Verkställande Direktör | 2019-01-15 |
TE Medical Consulting AB | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Tobias Larsson Agervald
| Företag | Position | Slut |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | - |
Tobias Larsson Agervalds utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
TE Medical Consulting AB |
















